Skip to content

Observation Study of the Clinical Management of Bipolar Disorder

Chinese Observation Study of the Clinical Management of Bipolar Disorder

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01770704
Enrollment
520
Registered
2013-01-18
Start date
2013-02-28
Completion date
2014-07-31
Last updated
2016-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bipolar Disorder

Keywords

Bipolar disorder, Clinical management, Clinical outcomes

Brief summary

The objective of the ambispective cohort study is to describe clinical management and clinical outcomes related to bipolar disorder in China, and establish the factors associated with different management patterns and clinical outcomes, provide psychiatrists with reliable and up-to-date information on the disease.

Interventions

None listed

Sponsors

AstraZeneca
Lead SponsorINDUSTRY

Study design

Observational model
COHORT

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Provision of subject informed consent. * Diagnosis of Bipolar Disorder I or II (DSM-IV TR) in any phase of the disorder. * Patients who had at least one mood event( depression, mania, hypomania or mixed) according to DSM-IV TR definition during the 3 and 12 months prior to the beginning of the study.

Exclusion criteria

* Inability to complete Patient Reported Outcomes (PROs) questionnaires. * Participation in an interventional clinical study in last 12 months.

Design outcomes

Primary

MeasureTime frame
Number of episodes (depression, mania, hypomania or mixed).Up to 21 months

Secondary

MeasureTime frame
Treatments received for Bipolar Disorder: medication time.Up to 21 months
Treatments received for Bipolar Disorder: medication classes.Up to 21 months

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 11, 2026